Retatrutide 10mg
10mg/vial · 10 vials per kit
$84.00
/ kit€840.00 per vial · Free shipping over €150
Retatrutide is a novel triple-agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. It is currently under active Phase 3 clinical investigation for metabolic research applications.
This higher-dose formulation (10mg/vial) is designed for research protocols requiring larger per-vial quantities, reducing preparation time and improving workflow efficiency in laboratory settings.
Each vial contains 10mg of lyophilized Retatrutide with verified purity ≥98.5% by HPLC analysis. Supplied as a kit of 10 vials. Certificate of Analysis included with every order.
This product is intended for laboratory research purposes only. Not for human consumption, veterinary use, or diagnostic procedures. Purchaser must be 18 years or older.